Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach

The aim of this study was to optimize the formulation of meloxicam (MEL)-containing human serum albumin (HSA) nanoparticles for nose-to-brain via a quality by design (QbD) approach. Liquid and dried formulations of nanoparticles containing Tween 80 and without the surfactant were investigated. Vario...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutics
Main Authors: Katona, Gábor, Balogh, György Tibor, Dargó, Gergő, Gáspár, Róbert, Márki, Árpád, Ducza, Eszter, Sztojkov-Ivanov, Anita, Tömösi, Ferenc, Kecskeméti, Gábor, Janáky, Tamás, Kiss, Tamás, Ambrus, Rita, Pallagi, Edina, Szabó-Révész, Piroska, Csóka, Ildikó
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7076499/
https://ncbi.nlm.nih.gov/pubmed/31991767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12020097
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items